Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-17 Purchase |
2021-08-17 4:08 pm |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
4,000 | $0.8955 | $3,582 | 102,247 (Indirect) |
View |
| 2021-08-10 Purchase |
2021-08-11 4:08 pm |
Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director |
7,000 | $0.881 | $6,167 | 18,350 (Indirect) |
View |
| 2020-08-21 Purchase |
2020-08-24 08:08 am |
Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director |
4,000 | $0.98 | $3,920 | 11,350 (Direct) |
View |
| 2020-08-19 Purchase |
2020-08-20 07:59 am |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
2,000 | $1.01 | $2,020 | 2,000 (Indirect) |
View |
| 2020-08-17 Purchase |
2020-08-18 08:35 am |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
5,000 | $1 | $5,000 | 12,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-20 Option Award |
2022-01-21 4:06 pm |
2023-01-19 2032-01-19 |
Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-21 4:05 pm |
2023-01-19 2032-01-19 |
Salarius Pharmaceuticals Inc. | SLRX | Lammers Paul Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-21 4:03 pm |
N/A 2032-01-19 |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
200,000 | $0 | 200,000 (Direct) |
View |
| 2021-11-03 Option Award |
2021-11-05 2:58 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
7,939 | $0.718 | 110,186 (Direct) |
View |
| 2021-11-03 Option Award |
2021-11-05 2:54 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
7,787 | $0.718 | 34,073 (Direct) |
View |
| 2021-05-03 Option Award |
2021-05-05 5:11 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
9,563 | $0.567 | 26,286 (Direct) |
View |
| 2021-05-03 Option Award |
2021-05-05 5:10 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
9,822 | $0.567 | 96,247 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-04 5:07 pm |
2021-12-01 2030-12-01 |
Salarius Pharmaceuticals Inc. | SLRX | Burleson Tess Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-04 5:05 pm |
N/A 2030-12-01 |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
275,000 | $0 | 275,000 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-04 5:03 pm |
2021-12-01 2030-12-01 |
Salarius Pharmaceuticals Inc. | SLRX | McVicar William K. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-04 5:02 pm |
N/A 2030-12-01 |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-04 5:00 pm |
2021-12-01 2030-12-01 |
Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-04 4:59 pm |
2021-12-01 2030-12-01 |
Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-04 4:56 pm |
2021-12-01 2030-12-01 |
Salarius Pharmaceuticals Inc. | SLRX | McCreedy Bruce J Jr. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-04 4:55 pm |
2021-12-01 2030-12-01 |
Salarius Pharmaceuticals Inc. | SLRX | Lammers Paul Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-11-03 Option Award |
2020-11-05 5:44 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
4,879 | $0.561 | 86,425 (Direct) |
View |
| 2020-11-03 Option Award |
2020-11-05 5:42 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
4,723 | $0.561 | 16,723 (Direct) |
View |
| 2020-07-14 Option Award |
2020-07-16 8:56 pm |
N/A 2030-07-13 |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
339,584 | $0 | 339,584 (Direct) |
View |
| 2020-07-14 Option Award |
2020-07-16 8:55 pm |
N/A 2030-07-13 |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
49,955 | $0 | 49,955 (Direct) |
View |
| 2020-07-14 Option Award |
2020-07-16 08:33 am |
N/A 2030-07-13 |
Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director |
3,000 | $0 | 3,000 (Direct) |
View |